Sponsored Links
| CombinatoRx Announces Extension Of Exalgo™ Extended-Release Tablets PDUFA Date To March 1, 2010 |
 |
 |
 |
| Pharmacy - Pharmacy - Pharmacist | |||
|
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for review of the Exalgo™ (hydromorphone HCl) extended-release tablets New Drug Application (NDA) from Monday, February 22, 2010 to Monday, March 1, 2010 due to federal government closings. The U.S... Read more: Pharmacy / Pharmacist News From Medical News Today
|